Does VEMURAFENIB Cause Squamous cell carcinoma? 172 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Squamous cell carcinoma have been filed in association with VEMURAFENIB (ZELBORAF). This represents 2.0% of all adverse event reports for VEMURAFENIB.
172
Reports of Squamous cell carcinoma with VEMURAFENIB
2.0%
of all VEMURAFENIB reports
4
Deaths
11
Hospitalizations
How Dangerous Is Squamous cell carcinoma From VEMURAFENIB?
Of the 172 reports, 4 (2.3%) resulted in death, 11 (6.4%) required hospitalization, and 3 (1.7%) were considered life-threatening.
Is Squamous cell carcinoma Listed in the Official Label?
Yes, Squamous cell carcinoma is listed as a known adverse reaction in the official FDA drug label for VEMURAFENIB.
What Other Side Effects Does VEMURAFENIB Cause?
Rash (1,202)
Arthralgia (783)
Off label use (782)
Fatigue (773)
Diarrhoea (655)
Nausea (601)
Pyrexia (569)
Death (505)
Alopecia (445)
Decreased appetite (383)
What Other Drugs Cause Squamous cell carcinoma?
ADALIMUMAB (456)
RUXOLITINIB (413)
TACROLIMUS (327)
INFLIXIMAB (313)
RITUXIMAB (313)
LENALIDOMIDE (304)
PREDNISONE (267)
RANITIDINE (260)
CYCLOSPORINE (254)
METHOTREXATE (252)
Which VEMURAFENIB Alternatives Have Lower Squamous cell carcinoma Risk?
VEMURAFENIB vs VENETOCLAX
VEMURAFENIB vs VENLAFAXINE
VEMURAFENIB vs VENTAVIS
VEMURAFENIB vs VENTOLIN
VEMURAFENIB vs VENTOLIN HFA